Noorik Biopharmaceuticals AG   Report issue

For profit Phase 2
Founded: Basel Switzerland (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2019
NCT03827200
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Noorik Biopharmaceuticals AG